Kezar Life Sciences : Failure to Satisfy Listing Rule Form 8 K
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed on a Current Report on Form 8-K filed by...
Nasdaq Stock Market Nasdaq Listing Qualifications Panel Kezar Life Sciences Inc Company On Continued Listing Rule Current Report
Source: marketscreener.com